Tenet Healthcare (THC) Set to Announce Quarterly Earnings on Tuesday

Tenet Healthcare (NYSE:THCGet Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, April 30th. Analysts expect Tenet Healthcare to post earnings of $1.41 per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

Tenet Healthcare (NYSE:THCGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported $2.68 EPS for the quarter, topping the consensus estimate of $1.58 by $1.10. Tenet Healthcare had a return on equity of 26.34% and a net margin of 2.97%. The business had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.28 billion. During the same period last year, the business posted $1.96 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. On average, analysts expect Tenet Healthcare to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Tenet Healthcare Price Performance

THC opened at $94.85 on Tuesday. The firm has a market cap of $9.41 billion, a price-to-earnings ratio of 16.61, a PEG ratio of 2.99 and a beta of 2.08. The company has a current ratio of 1.51, a quick ratio of 1.42 and a debt-to-equity ratio of 4.77. The stock’s 50-day moving average price is $97.56 and its 200 day moving average price is $79.67. Tenet Healthcare has a 12-month low of $51.04 and a 12-month high of $107.80.

Analysts Set New Price Targets

THC has been the subject of several recent research reports. Wolfe Research raised shares of Tenet Healthcare from a “peer perform” rating to an “outperform” rating and set a $122.00 price target for the company in a research report on Wednesday, March 27th. TheStreet upgraded shares of Tenet Healthcare from a “c+” rating to a “b-” rating in a research note on Tuesday, February 6th. Deutsche Bank Aktiengesellschaft increased their target price on Tenet Healthcare from $100.00 to $126.00 and gave the company a “buy” rating in a report on Friday, April 12th. Wells Fargo & Company upped their price objective on Tenet Healthcare from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, March 28th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $104.00 price objective on shares of Tenet Healthcare in a report on Wednesday, April 10th. One analyst has rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $100.38.

Read Our Latest Report on Tenet Healthcare

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, EVP Paola M. Arbour sold 18,168 shares of the business’s stock in a transaction on Wednesday, March 6th. The shares were sold at an average price of $96.96, for a total value of $1,761,569.28. Following the transaction, the executive vice president now directly owns 29,803 shares of the company’s stock, valued at approximately $2,889,698.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Tenet Healthcare news, Director Richard W. Fisher sold 2,100 shares of the firm’s stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $88.21, for a total value of $185,241.00. Following the completion of the sale, the director now owns 20,127 shares of the company’s stock, valued at $1,775,402.67. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, EVP Paola M. Arbour sold 18,168 shares of the company’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $96.96, for a total transaction of $1,761,569.28. Following the transaction, the executive vice president now directly owns 29,803 shares in the company, valued at $2,889,698.88. The disclosure for this sale can be found here. Insiders sold a total of 51,268 shares of company stock valued at $4,944,810 in the last ninety days. Insiders own 1.30% of the company’s stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Stories

Earnings History for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.